InjectCo sources from licensed 503B pharmacies and requires a full provider evaluation before prescribing
Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, et al
GLP-1 receptor agonists (GLP-1 RAs) are approved for the treatment of type 2 diabetes and obesity and have gained widespread use due to their effectiveness in reducing both A1c levels and body weight
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation
,
While some clients may notice results right away, most experience the full benefits within a week, including improved energy levels, enhanced vitality, and overall wellness support